US Patent Issued to Azura Ophthalmics on Sept. 30 for "Compositions and methods for the treatment of meibomian gland dysfunction" (Israeli, American Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,427,158, issued on Sept. 30, was assigned to Azura Ophthalmics Ltd. (Tel Aviv, Israel).

"Compositions and methods for the treatment of meibomian gland dysfunction" was invented by Yair Alster (Tel Aviv, Israel), Omer Rafaeli (Udim, Israel), Kirsten Angela MacFarlane (Menlo Park, Calif.), Cary Reich (Santa Barbara, Calif.), Shimon Amselem (Rehovot, Israel) and Doron Friedman (Karmei Yosef, Israel).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are compositions and methods for the treatment of meibomian gland dysfunction. Said compositions and methods comprise keratolytic agents, such as salicylic acid, selenium disulfide, or the like. To...